- Apr 18/24
FDA fast-tracks AskBio’s heart failure gene therapy - Apr 18/24
Cell therapy weekly: First patient treated in frontotemporal dementia gene therapy trial - Apr 17/24
Manitoba’s first CAR T-cell therapy patient declared cancer-free - Apr 17/24
A slow embrace: Hemophilia’s gradual adoption of gene therapy - Apr 17/24
Lilly’s Prevail walks away from gene editing collab with Precision - Apr 15/24
Advance in immune cell screening uncovers receptors that target prostate cancer - Apr 15/24
Real-world data fill knowledge gap to assess treatment options for infants with spinal muscular atrophy - Apr 12/24
CRISPR technologies fuelling hematological innovations - Apr 12/24
The effort to make a breakthrough cancer therapy cheaper - Apr 12/24
Scientists produce in vitro model of cell differentiation during early facial development - Apr 11/24
Gairdner Awards 2024 honour pioneering work in health research - Apr 11/24
Can we crack the code of cartilage? - Apr 11/24
Researchers stimulate gene that enhances CAR T-cell treatments for solid tumours - Apr 10/24
Study reveals inequities in access to transformative CAR T cell therapy - Apr 10/24
How to supercharge cancer-fighting cells: give them stem cell skills - Apr 10/24
CHOP, Stanford researchers identify protein that controls CAR T cell longevity - Apr 10/24
Study examines side effects observed with SMA gene therapy - Apr 10/24
This start-up wants to be OpenAI of stem cell therapy, targets $250B market - Apr 9/24
Could CAR-T cell therapy improve kidney transplants? - Apr 9/24
CRISPR concerns won’t spoil its promise — If we use the right tools - Apr 9/24
Unleashing CAR-T cell therapy to destroy solid tumours in thyroid cancer - Apr 9/24
Former bluebird execs hope to fly new startup to “cutting edge” of gene therapy delivery tech - Apr 8/24
Spine surgeons see promise in biologics, regenerative medicine - Apr 7/24
Unlocking the healing potential of dental stem cells - Apr 5/24
Adeno-associated virus: The gene therapy revolution faces manufacturing and safety hurdles - Apr 5/24
US FDA allows expanded use of Bristol Myers’ cell therapy for blood cancer - Apr 5/24
Gene therapy: Viral vector technology innovators prepare for take-off - Apr 4/24
Developing artificial skin that can regenerate skin and transmit sensation at the same time - Apr 4/24
Scientists propose AI framework for mass-manufacturing of stem cells for regenerative medicine - Apr 4/24
Promising results: gene therapy for giant axonal neuropathy shows early benefits - Apr 3/24
A new computational technique could make it easier to engineer useful proteins - Apr 2/24
Could CAR-T cell therapy improve kidney transplants? - Apr 2/24
New insights into muscle health: How innervation influences the recovery process - Apr 2/24
What’s next for AAV gene therapies in 2024? - Apr 2/24
This bag of cells could grow new livers inside of people - Apr 2/24
Verve Therapeutics pauses enrolment in early-stage gene therapy study for high cholesterol levels - Apr 1/24
MEGA CRISPR: Engineering better immunotherapies with RNA editing - Apr 1/24
Utah flouts FDA with law greenlighting placental stem cell therapies - Apr 1/24
Emerging frontiers in immunotherapy: The promise of NK-cell therapies - Apr 1/24
Study documents safety, improvements from stem cell therapy after spinal cord injury - Mar 28/24
Signatures of autofluorescence used to study stem cells aging in the brain - Mar 27/24
Sensory neurons play pivotal role in orchestrating tissue repair and regeneration - Mar 27/24
Robots and AI: The future of cell and gene therapy manufacturing - Mar 27/24
Gene therapy, DNA’s past, RNA’s future: Early history - Mar 26/24
Study reveals inequities in access to CAR T cell therapy - Mar 26/24
New genetic analysis tool tracks risks tied to CRISPR edits - Mar 26/24
Research unveils metabolic strategies to enhance CAR-T cell therapy - Mar 25/24
BlueRock Therapeutics and Foundation Fighting Blindness announce collaboration to expand the Uni-Rare natural history study of patients living with inherited retinal diseases - Mar 25/24
Engineers develop novel method for manufacturing CAR T cells using lipid nanoparticles - Mar 25/24
Process optimization: a tool to widen cell therapy access - Mar 25/24
Epigenetic editing explodes on the heels of gene editing success - Mar 25/24
Stem cell model offers first glimpse of early human development - Mar 21/24
Eight CAR-T cell therapy companies you should know about - Mar 20/24
FDA’s Marks says global dialogue on gene therapy regulation key for patient access - Mar 20/24
Aging affects regulatory T cells’ ability to promote myelin regeneration - Mar 20/24
Highly adhesive, mechanically strong adhesive addresses multiple limitations in dural membrane repair - Mar 20/24
Cell therapy approach could be key for rare liver cancer - Mar 20/24
Gene therapy for pain treatment - Mar 19/24
Cell therapies show promise for addressing Parkinson’s disease non-motor symptoms - Mar 19/24
FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma - Mar 19/24
Human avatars help make gene therapy more effective